Skip to Content
Merck
All Photos(1)

Key Documents

755303

Sigma-Aldrich

3-Amino-2-fluoropropionic acid

95%

Synonym(s):

DL-2-Fluoro-β-alanine

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C3H6FNO2
CAS Number:
Molecular Weight:
107.08
EC Number:
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Quality Level

Assay

95%

form

solid

mp

240-245 °C

functional group

amine
carboxylic acid
fluoro

SMILES string

NCC(F)C(O)=O

InChI

1S/C3H6FNO2/c4-2(1-5)3(6)7/h2H,1,5H2,(H,6,7)

InChI key

OJQNRNQELNLWHH-UHFFFAOYSA-N

Related Categories

Pictograms

CorrosionExclamation mark

Signal Word

Danger

Hazard Statements

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Skin Irrit. 2 - STOT SE 3

Target Organs

Respiratory system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Jean-Louis Fischel et al.
Anti-cancer drugs, 15(10), 969-974 (2004-10-30)
Capecitabine (Xeloda) is a very active oral fluoropyrimidine (colon and breast cancers) whose clinical use is complicated by the presence of hand-foot syndrome (HFS). This cutaneous toxicity is less frequently encountered with other oral fluoropyrimidines containing a dihydropyrimidine dehydrogenase (DPD)
Ronald Gieschke et al.
British journal of clinical pharmacology, 55(3), 252-263 (2003-03-13)
To assess the relationship between systemic exposure to capecitabine metabolites and parameters of efficacy and safety in patients with advanced or metastatic colorectal cancer from two phase III studies. Concentration-effect analyses were based on data from 481 patients (248 males
Kazumasa Yamashita et al.
The Journal of toxicological sciences, 29(2), 155-166 (2004-06-23)
In order to clarify the mechanism of the neurotoxicity of 5-FU and/or its masked compounds, we studied the effects of alpha-fluoro-beta-alanine (FBAL) and fluoroacetic acid (FA) on the formation of vacuolar changes in the dog cerebrum, using the dosage of
S Ndaw et al.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 878(27), 2630-2634 (2010-03-09)
A new sensitive and specific HPLC-MS/MS method for the determination of α-fluoro-β-alanine (FBAL), the main metabolite of the antineoplastic drug 5-fluorouracil (5-FU), in urine for the biological monitoring survey of health care workers exposed to 5-FU is described. This procedure
Yasuhide Yamada
Gan to kagaku ryoho. Cancer & chemotherapy, 33 Suppl 1, 37-41 (2006-08-11)
The pharmacokinetics and pharmacodynamics of oral S-1, a dihydropyrimidine dehydrogenase (DPD) inhibitory fluoropyrimidine, were compared with those of protracted venous infusion (PVI) of 5-fluorouracil (5-FU). In all, 10 patients with gastric cancer received PVI of 5-FU at a dose of

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service